Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 70 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery				Phase IV				03/2007 NCT00719017
	Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer				Phase III				GOG-0209 GOG-0209, NCT00063999
	Laparoscopic Approach to Cancer of the Endometrium				Phase III				LACE001 NCT00096408
	Chemotherapy and Radiation Therapy Compared With Radiation Therapy Alone in Treating Patients With High-Risk Stage I, Stage II, or Stage III Endometrial Cancer				Phase III				CKTO-2006-04 ISRCTN14387080, CKTO-PORTEC-3, EU-20664, NCT00411138
	Prospective Randomized Open Label Study of the Treatment of Therapy-Associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium -				Phase III				2006-002948-28 KKS-73-05, NCT00444093
	The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas				Phase III				SARC-GYN1 NCT00162721
	Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients				Phase III				EPO316 JP NCT00628043
	Trial of Collagen Mesh for Prevention of Ventral Hernia After Surgery for Advanced Pelvic Cancer				Phase III				VRAM M-20070240 NCT00647569
	Intensity Modulated Radiation Therapy - Gyne Cancer				Phase II, Phase I				UHN REB 03-0298-C NCT00188578
	Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma				Phase II, Phase I				GYN03-0177 NCT00506779


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute